UCB announced positive topline results from C-AXSPAND, a Phase 3 placebo controlled study to investigate the efficacy of CIMZIA® (certolizumab...
Read more
Zymeworks Inc. , a clinical-stage biopharmaceutical company developing multifunctional therapeutics, and Daiichi Sankyo Company, Limited announced that they entered into...
Read more
Eli Lilly and Company announced that new results from a number of studies across the company's oncology product and pipeline...
Read more
Eli Lilly and Company announced that galcanezumab met its primary endpoint in a Phase 3 study of patients with episodic...
Read more
Teva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...
Read more
HDA’s Pharmaceutical Cargo Security Coalition (PCSC) presented three awards at its educational seminar in East Hanover, New Jersey. Presented annually,...
Read more
Novartis announced the plan to initiate ARROW, a head-to-head proof of concept study to assess the mechanistic superiority of the...
Read more
Boehringer Ingelheim, the world’s second largest animal health company, has been boosting its investment in China by expanding the Asian...
Read more
Sumitomo Dainippon Pharma Co., Ltd. announced that it has signed an agreement with Medicines for Malaria Venture (Geneva, Switzerland; "MMV") on...
Read more
Amgen announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
